Skip to main content

Ear

  • Chapter
  • First Online:
Practical Pharmaceutics
  • 1125 Accesses

Abstract

This chapter deals with formulation and preparation of ear drops for application to the external auditory canal as well as those intended for the middle ear. Creams and ointments for the ear are similar to semisolid preparations for cutaneous use.

The most used ear drops prepared in pharmacies are discussed for their formulation (solvent, pH, osmotic value, preservation), method of preparation, packaging, storage and methods of administration.

The formulation of ear drops, especially the choice of the vehicle, depends on the site of action: the external auditory canal or the middle ear. When ear drops get to the middle ear, they may come into contact with the inner ear and so cause ototoxicity. Because of the ototoxicity of active substances, non-aqueous vehicles and many other excipients, special precautions are needed in formulations that should, or may accidentally, come into contact with the middle ear. Preparations intended for the middle ear are aqueous, sterile and preferably iso-osmotic. When non-aqueous vehicles are used in ear drops for the external auditory canal, it depends on the state of the patient’s ear drum whether they will reach the middle ear.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Zure oordruppels met hydrocortison 1 % FNA. Jaar 2009. Formularium der Nederlandse Apothekers. Den Haag: Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie (KNMP)

    Google Scholar 

  2. Aluminium Acetate Ear Drops. British Pharmacopoeia 2014. The Stationary Office, London

    Google Scholar 

  3. Thorp MA, Kruger J, Oliver S, Nilssen EL, Prescott CA (1998) The antibacterial acidity of acetic acid and Burow’s solution as topical otological preparations. J Laryngol Otol 112:925–928

    Article  CAS  PubMed  Google Scholar 

  4. Goycoolea MV, Jung TK (1991) Complications of suppurative otitis media. In: Paparella MM, Shumrick DA, Gluckman JL, Meyerhoff WL (eds) Otolaryngology, vol 2. WB Saunders, Philadelphia, pp 1381–1403

    Google Scholar 

  5. Glassman JM, Pillar J, Soyka JP (1978) Otitis external: comparative in vitro sensitivities of clinical isolates of bacteria and fungi to nonantibiotic and antibiotic otic preparations. Curr Ther Res Clin Exp 23:S29–S38

    Google Scholar 

  6. Brook I, Finegold SM (1979) Bacteriology of chronic otitis media. JAMA 241:487–488

    Article  CAS  PubMed  Google Scholar 

  7. Burton MJ, Doree C (2009) Ear drops for the removal of ear wax. Cochrane Database Syst Rev 1:Art. No.: CD004326. https://doi.org/10.1002/14651858.CD004326.pub2. Accessed 15 Mar 2013

    Article  Google Scholar 

  8. Farmacotherapeutisch Kompas. Aandoeningen van de uitwendige gehoorgang www.fk.cvz.nl. Accessed 15 Mar 2013

  9. Ă–lige Clotrimazol-Ohrentropfen 1% NRF 16.4. Fassung 2010. Neues Rezeptur-Formularium. GOVI-Verlag Pharmazeutischer Verlag GMBH, Eschborn. Deutscher Apotheker-Verlag, Stuttgart

    Google Scholar 

  10. Dohar J (2004) Eardrops for Otorrhoea. In: Alper CM, Bluestone C, Dohar JE, Mandel EM, Casselbrant ML (eds) Advanced therapy of otitis media. BC Decker Publications, Hamilton, pp 246–253

    Google Scholar 

  11. Swan EEL, Mescher MJ, Sewell WF, Toa SL, Borenstein JT (2008) Inner ear drug delivery for auditory applications. Adv Drug Deliv Rev 60:1583–1599

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Richardson RT, Wise AK, Andrew JK, O’Leary SJ (2008) Novel drug delivery systems for inner ear protection and regeneration after hearing loss. Expert Opin Drug Deliv 5:1059–1076

    Article  CAS  PubMed  Google Scholar 

  13. Haynes DS, Rutka J, Hawke M, Roland PS (2007) Ototoxicity of ototopical drops – an update. Otolaryngol Clin N Am 40:669–683

    Article  Google Scholar 

  14. Goycoolea MV (2001) Clinical aspects of round window permeability under normal and pathological conditions. Acta Otolaryngol (Stockh) 121:437–447

    Article  CAS  PubMed  Google Scholar 

  15. Goycoolea MV, Muchow D, Schachern PA (1988) Experimental studies on round window membrane structure function and permeability. Laryngoscope 98(Suppl. 44):1–20

    Article  CAS  PubMed  Google Scholar 

  16. Guthrie OW (2008) Aminoglycoside induced toxicity. Toxicology 249:91–96

    Article  PubMed  Google Scholar 

  17. Munguia R, Daniel SJ (2008) Ototopical antifungals and otomycosis: a review. Int J Pediatr Otorhinolaryngol 72:453–459

    Article  PubMed  Google Scholar 

  18. Van der Hulst RJAM (2001) Ototoxiciteit van oordruppels. Het standpunt van de KNO-vereniging. Pharm Weekbl 136:495–497

    Google Scholar 

  19. Miconazol oordruppels 2% FNA. Jaar 2009. Formularium der Nederlandse Apothekers. Den Haag: Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie (KNMP)

    Google Scholar 

  20. The normal microbial flora of the outer ear canal in healthy Norwegian individuals W L Dibb. https://pubmed.ncbi.nlm.nih.gov/221604/

  21. Kim JK, Cho JH (2009) Change of external auditory canal pH in acute otitis externa. Ann Otol Rhinol Laryngol 118(11):769–772

    Article  PubMed  Google Scholar 

  22. Horikx A (2005) Boorzuur in oogdruppels ook beneden 3 jaar. Pharm Weekbl 140:82

    Google Scholar 

  23. Aluminiumacetotartraatoordruppels 12% FNA. Jaar 2009. Formularium der Nederlandse Apothekers. Den Haag: Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie (KNMP)

    Google Scholar 

  24. Aluminiumacetotartraatoordruppels 1,2% FNA. Jaar 2009. Formularium der Nederlandse Apothekers. Den Haag: Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie (KNMP)

    Google Scholar 

  25. Efficacy of Boric Acid as a Treatment of Choice for Chronic Suppurative Otitis Media and Its Ototoxicity Indri Adriztina, Linda Irwani Adenin, and Yuliani Mardiati Lubis https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788841/

  26. Citric Acid as an Alternative to Boric Acid in the Treatment of Chronic Suppurative Otitis Media Basavraj Nagoba* and Milind Davane https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669388/

  27. Role of Clotrimazole in Prevention of Recurrent Otomycosis Keyvan Kiakojuri, 1 Ramazan Rajabnia, 2 , 3 Saeid Mahdavi Omran, 2 , 4 Abazar Pournajaf, 2, 3 Mohsen Karami, 4 and Mojtaba Taghizadeh Armaki 2, 4 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944967/

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Monja Gantumur .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gantumur, M., Russell, C. (2023). Ear. In: Le Brun, P., Crauste-Manciet, S., Krämer, I., Smith, J., Woerdenbag, H. (eds) Practical Pharmaceutics. Springer, Cham. https://doi.org/10.1007/978-3-031-20298-8_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-20298-8_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-20297-1

  • Online ISBN: 978-3-031-20298-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics